Corbevax is currently being administered to children in the age group 12-14 years. Hyderabad based Biological E had approached the drug reg...

"Our price to the government programme is ₹145, the lowest in the country and possibly the world," Datla said. "It's something we take grea...

It is the fourth vaccine to receive the regulator's nod for use among those below 18 years.

The pandemic is not over. There is a need to ensure universal vaccination at home and abroad. India needs to move quickly on its domestic r...

Corbevax, is a RBD protein sub-unit vaccine that has been developed with support from the Department of Biotechnology and the Biotechnology...

The Drugs Controller General Of India (DCGI) has already approved Corbevax, which is India's first indigenously developed RBD protein sub-u...

Both SII and Biological E are conducting Phase III trials of their vaccines on children. These could become the next choices of vaccines fo...

The government had placed an order for Corbevax even before it received emergency use authorisation (EUA). It paid ₹1,500 crore in advance ...

Sputnik V is a two-dose vaccine made from two components - recombinant adenovirus 26 or Ad26 and adenovirus 5 or Ad5 The first dose (Ad26) ...

Taranjit Singh Sandhu, India's Ambassador to the US, in a tweet described it as a model of India-US healthcare collaboration. "Models of wh...

Experience with the Omicron variant so far makes clear that while vaccines are critical for reducing the virulence of the disease, therapie...

Union Health Minister Mansukh Mandaviya on Tuesday said that the Central Drug Authority CDSCO has approved the Serum Institute of India's C...

The recommendations have been sent to the Drug Controller General of India (DCGI), which will soon decide on their approval, people in the ...

The SEC on COVID-19 of the CDSCO, which reviewed the emergency use authorisation (EUA) applications of Serum Institute of India (SII) for t...

The subject experts committee (SEC), a body under India's drug regulator, will meet on Monday to review the applications for granting appro...

The government had in a presentation in May estimated that 216 crore vaccines will be available in the country between August and December.

Of these, the phase-three trials of Corbevax — jointly manufactured by BE, Baylor College of Medicine in Houston and Dynavax in California ...